Mechanism of action of a new class of insulin secretagogues

Experimental and Clinical Endocrinology and Diabetes

Volumn 107, Issue SUPPL. 4, 1999, Pages

  Malaisse, Willy J ^a,b  

^a FREE UNIVERSITY OF BRUSSELS   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Mechanism of action; Meglitinide family; Repaglinide

Indexed keywords

ANTIDIABETIC AGENT; CALCIUM ION; DIAZOXIDE; GLIBENCLAMIDE; GLUCAGON; GLUCOSE; INSULIN; INSULIN SECRETAGOGUE; MEGLITINIDE; PEPTIDE; POTASSIUM CHANNEL; POTASSIUM ION; REPAGLINIDE; RUBIDIUM 86; SOMATOSTATIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CALCIUM TRANSPORT; CONFERENCE PAPER; CONTROLLED STUDY; DRUG BINDING; GLUCAGON RELEASE; GLUCOSE METABOLISM; INSULIN RELEASE; INSULINOMA; NONHUMAN; NUTRIENT; PANCREAS ISLET CELL; PEPTIDE SYNTHESIS; POTASSIUM CONDUCTANCE; PRIORITY JOURNAL; RAT; SOMATOSTATIN RELEASE;

EID: 0032858577     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1212170     Document Type: Conference Paper

References (26)

1. Bakkali-Nadi A, Malaisse-Lagae F, Malaisse WJ: Ionophoretic activity of meglitinide analogues. Diabetes Res 27: 61-71, 1994a
2. Bakkali-Nadi A, Malaisse-Lagae F, Malaisse WJ: Insulinotropic action of meglitinide analogs: concentration-response relationship and nutrient dependency. Diabetes Res 27: 81-87, 1994b
3. Bakkali-Nadi A, Malaisse-Lagae F, Malaisse WJ: Ionophoretic properties of the non-sulfonylurea hypoglycemic agents A-4166 and KAD-1229. Res Commun Mol Pathol Pharmacol 88: 339-347, 1995
4. Fuhlendorff J, Rorsman P, Kofod H, Brand CL, Rolin B, MacKay P, Shymko R, Carr RD: Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes. Diabetes 47: 345-351, 1998
5. García-Martínez JA, Villanueva-Peñacarrillo ML, Valverde I, Björkling F, Malaisse WJ: Stimulation of insulin release and potentiation of the insulinotropic action of antidiabetic agents by 1,2,3-tri(methylsuccinyl)glycerol ester in anaesthetized rats. Pharmacol Res 36: 369-372, 1997
6. Jijakli H, Malaisse WJ: Preservation of protein biosynthesis in rat pancreatic islets exposed to A-4166. Med Sci Res 25: 813-814, 1997
7. Jijakli H, Ulusoy S, Malaisse WJ: Dissociation between the potency and reversibility of the insulinotropic action of two meglitinide analogues. Pharmacol Res 34: 105-108, 1996
8. Jijakli H, Ulusoy S, Malaisse WJ: Dynamics of the cationic and secretory responses to A-4166 in perifused pancreatic islets. Fundam Clin Pharmacol 11: 300-304, 1997
9. Ladrière L, Malaisse-Lagae F, Fuhlendorff J, Malaisse WJ: Repaglinide, glibenclamide and glimepiride administration to normal and hereditarily diabetic rats. Eur J Pharmacol 335: 227-234, 1997a
10. Ladrière L, Malaisse-Lagae F, Fuhlendorff J, Malaisse WJ: Effect of antidiabetic agents on the increase in glycemia and insulinemia caused by refeeding in hereditarily diabetic rats. Res Commun Mol Pathol Pharmacol 97: 53-59, 1997b
11. Laghmich A, Ladrière L, Malaisse-Lagae F, Malaisse WJ: Pancreatic islet responsiveness to D-glucose after repeated administration of repaglinide. Eur J Pharmacol 348: 265-270, 1998
12. Leclercq-Meyer V, Ladrière L, Fuhlendorff J, Malaisse WJ: Stimulation of insulin and somatostatin release by two meglitinide analogs. Endocrine 7: 311-317, 1997
13. Lins L, Brasseur R, Malaisse WJ: Conformational analysis of non-sulfonylurea hypoglycemic agents of the meglitinide family. Biochem Pharmacol 50: 1879-1884, 1995a
14. Lins L, Brasseur R, Malaisse WJ: Conformational analysis of the calcium complexes formed by meglitinide analogs. Res Commun Mol Pathol Pharmacol 90: 153-164, 1995b
15. Louchami K, Jijakli H, Sener A, Malaisse WJ: Effect of repaglinide upon nutrient metabolism, biosynthetic activity, cationic fluxes and insulin release in rat pancreatic islets. Res Commun Mol Pathol Pharmacol 99: 155-168, 1998a
16. Louchami K, Ladrière L, Jijakli H, Malaisse WJ: Effect of repaglinide on insulin secretion in islets from rats infused for two days with a hypertonic solution of d-glucose. Endocrine 8: 247-250, 1998b
17. Malaisse WJ: The beta cell in NIDDM: giving light to the blind. Diabetologia 37 (Suppl 2): S36-S42, 1994
18. Malaisse WJ: Stimulation of insulin release by non-sulfonylurea hypoglycemic agents: the meglitinide family. Horm Metab Res 27: 263-266, 1995a
19. + concentrations. Pharmacol Res 32: 111-114, 1995b
20. Malaisse WJ, Sato F: Insulinotropic action of (2S)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl) propionate. I. Secretory and cationic aspects. Gen Pharmacol 26: 1313-1318, 1995
21. Malaisse WJ, Sener A: Effect of N-[(trans-4-isopropylcyclohexyl)-carbonyl]-D-phenylalanine on nutrient catabolism in rat pancreatic islets. Gen Pharmacol 31: 451-454, 1998
22. Sener A, Malaisse-Lagae F, Ulusoy S, Leclerq-Meyer V, Malaisse WJ: Contrasting secretory behaviour of pancreatic islets from old rats in two models of non-insulin-dependent diabetes. Diabetes Res 31: 67-76, 1996
23. 45Ca outflow and insulin release in pancreatic islets. Diabetes Res 31: 27-31, 1996
24. 2+-induced insulin release. Med Sci Res 23: 371-372, 1995
25. Viñambres C, García-Martínez JA, Villanueva-Peñacarrillo ML, Valverde I, Malaisse WJ: Preservation of nutrient-stimulated biosynthetic activity in pancreatic islets exposed to a meglitinide analogue. Med Sci Res 23: 779-780, 1995
26. Viñambres C, Villanueva-Peñacarrillo ML, Valverde I, Malaisse WJ: Repaglinide preserves nutrient-stimulated biosynthetic activity in rat pancreatic islets. Pharmacol Res 34: 83-85, 1996